Certificates of Analysis for Klow list this component under its full name, thymosin beta-4, rather than the TB-500 shorthand
Common side effects (rare): Temporary fatigue in first 3-5 days Mild headaches Injection site redness Increased appetite Vivid dreams (uncommon) Serious side effects (very rare): Allergic reaction to peptide Injection site infection (poor technique) Dizziness or lightheadedness Who shouldn't use BPC-157: Pregnant or breastfeeding women Active cancer diagnosis (promotes angiogenesis) Recent retinal surgery (blood vessel growth in eye) Known allergy to peptides Drug interactions: BPC-157 doesn't interact with most medications, but combining with: NSAIDs: BPC-157 protects against NSAID damage (actually beneficial) Blood thinners: Monitor closely due to angiogenesis effects Immunosuppressants: May reduce BPC-157 effectiveness Dosing mistakes to avoid Get the protocol right from the start
They consider several factors including your current symptoms, lab work, medical history, previous response to GLP-1 therapy, activity level, and treatment goals
Among them, branched ubiquitin chains, in which one ubiquitin moiety is modified with two or more ubiquitin molecules through different linkages, function as a priority signal for proteasome-mediated protein degradation 3,4